Indefinite Delivery Contract SPE2DB25D9348

The key features of this federal contract IDV award are as follows:

The Defense Logistics Agency (DLA) awarded a single-award indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The IDC, valued at up to $499,999,999, runs through November 30, 2026 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group supplies an extensive array of medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, which are primarily delivered to the DLA's Medical Supply Chain division for distribution to various Department of Defense (DoD) healthcare facilities globally. This IDC complements the company's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying its position as a crucial supplier in the federal pharmaceutical supply chain.

Through this contract, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. The contract aims to ensure a reliable and comprehensive supply of pharmaceuticals to meet the recurring medical requirements of DoD healthcare facilities worldwide.